275 related articles for article (PubMed ID: 23246550)
1. Cost-effectiveness of childhood influenza vaccination in England and Wales: Results from a dynamic transmission model.
Pitman RJ; Nagy LD; Sculpher MJ
Vaccine; 2013 Jan; 31(6):927-42. PubMed ID: 23246550
[TBL] [Abstract][Full Text] [Related]
2. Health and economic impact of the seasonal influenza vaccination programme in England.
Baguelin M; Jit M; Miller E; Edmunds WJ
Vaccine; 2012 May; 30(23):3459-62. PubMed ID: 22446636
[TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of vaccinating pregnant women against seasonal influenza in England and Wales.
Jit M; Cromer D; Baguelin M; Stowe J; Andrews N; Miller E
Vaccine; 2010 Dec; 29(1):115-22. PubMed ID: 21055501
[TBL] [Abstract][Full Text] [Related]
4. Extending the elderly- and risk-group programme of vaccination against seasonal influenza in England and Wales: a cost-effectiveness study.
Baguelin M; Camacho A; Flasche S; Edmunds WJ
BMC Med; 2015 Oct; 13():236. PubMed ID: 26459265
[TBL] [Abstract][Full Text] [Related]
5. The cost effectiveness of influenza vaccination for adults aged 50 to 64 years: a model-based analysis for Spain.
Aballéa S; De Juanes JR; Barbieri M; Martin M; Chancellor J; Oyagüez I; Verwee B; Largeron N
Vaccine; 2007 Sep; 25(39-40):6900-10. PubMed ID: 17764790
[TBL] [Abstract][Full Text] [Related]
6. Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation.
Baguelin M; Hoek AJ; Jit M; Flasche S; White PJ; Edmunds WJ
Vaccine; 2010 Mar; 28(12):2370-84. PubMed ID: 20096762
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of influenza vaccination in working-age cancer patients.
Avritscher EB; Cooksley CD; Geraci JM; Bekele BN; Cantor SB; Rolston KV; Elting LS
Cancer; 2007 Jun; 109(11):2357-64. PubMed ID: 17457827
[TBL] [Abstract][Full Text] [Related]
8. Estimating the clinical impact of introducing paediatric influenza vaccination in England and Wales.
Pitman RJ; White LJ; Sculpher M
Vaccine; 2012 Feb; 30(6):1208-24. PubMed ID: 22178725
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of a recommendation of universal mass vaccination for seasonal influenza in the United States.
Clements KM; Chancellor J; Nichol K; DeLong K; Thompson D
Value Health; 2011; 14(6):800-11. PubMed ID: 21914499
[TBL] [Abstract][Full Text] [Related]
10. Cost-Effectiveness of Routine Childhood Vaccination Against Seasonal Influenza in Germany.
Scholz SM; Weidemann F; Damm O; Ultsch B; Greiner W; Wichmann O
Value Health; 2021 Jan; 24(1):32-40. PubMed ID: 33431151
[TBL] [Abstract][Full Text] [Related]
11. The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia.
Newall AT; Scuffham PA; Kelly H; Harsley S; Macintyre CR
Vaccine; 2008 Apr; 26(17):2142-53. PubMed ID: 18343537
[TBL] [Abstract][Full Text] [Related]
12. Estimating the impact of childhood influenza vaccination programmes in England and Wales.
Vynnycky E; Pitman R; Siddiqui R; Gay N; Edmunds WJ
Vaccine; 2008 Sep; 26(41):5321-30. PubMed ID: 18647634
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales.
Melegaro A; Edmunds WJ
Vaccine; 2004 Oct; 22(31-32):4203-14. PubMed ID: 15474710
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of influenza vaccination of healthy children.
Salo H; Kilpi T; Sintonen H; Linna M; Peltola V; Heikkinen T
Vaccine; 2006 Jun; 24(23):4934-41. PubMed ID: 16678945
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness and socio-economic aspects of childhood influenza vaccination.
Nichol KL
Vaccine; 2011 Oct; 29(43):7554-8. PubMed ID: 21820477
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: A lifetime multi-cohort model.
Yang MC; Tan EC; Su JJ
Hum Vaccin Immunother; 2017 Jan; 13(1):81-89. PubMed ID: 27624648
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of influenza vaccination of people aged 50-64 years in Australia: results are inconclusive.
Mogasale V; Barendregt J
Aust N Z J Public Health; 2011 Apr; 35(2):180-6. PubMed ID: 21463417
[TBL] [Abstract][Full Text] [Related]
18. The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model.
Aballéa S; Chancellor J; Martin M; Wutzler P; Carrat F; Gasparini R; Toniolo-Neto J; Drummond M; Weinstein M
Value Health; 2007; 10(2):98-116. PubMed ID: 17391419
[TBL] [Abstract][Full Text] [Related]
19. Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands.
de Boer PT; Nagy L; Dolk FCK; Wilschut JC; Pitman R; Postma MJ
Value Health; 2021 Jan; 24(1):19-31. PubMed ID: 33431149
[TBL] [Abstract][Full Text] [Related]
20. Expanding the recommendations for annual influenza vaccination to school-age children in the United States.
Fiore AE; Epperson S; Perrotta D; Bernstein H; Neuzil K
Pediatrics; 2012 Mar; 129 Suppl 2():S54-62. PubMed ID: 22383482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]